Inflection Point Ventures

Inflection Point Ventures, or IPV, is one of the larger angel networks in India, headquartered in Gurugram and structured as a syndicate of vetted high-net-worth individuals who deploy capital into early-stage tech-enabled startups. Check sizes are typically in the $250K to $1M range across pre-seed, seed, and early Series A, and the network has invested in hundreds of companies since its founding, with healthcare being one of several active categories. IPV is not a traditional venture fund with a partnership-led decision structure; it is a curated syndicate, which has both advantages and disadvantages for founders. The advantages are speed of decisioning when the deal resonates with the network, broad distribution of strategic angel investors who can open doors in their respective industries, and a relatively founder-friendly process. The disadvantages are that the network is generalist rather than healthcare-specialist, the post-investment support is unevenly distributed across the angel base, and the brand carries less weight with downstream Series A leads than top-tier institutional VCs. The right founder profile is an early-stage Indian tech-enabled healthcare or health IT founder who needs a credible early round to validate metrics before approaching institutional Series A investors, and who values the breadth of an angel network’s industry connections. The wrong fit is a deep-tech biotech that needs specialist diligence and patient capital, or a founder seeking a single conviction-driven institutional partner. The right entry path is through the IPV application process, which is open and reasonably structured, supplemented by warm referrals from network members or existing portfolio CEOs. The firm runs regular pitch sessions where founders can present to a curated angel audience. When pitching, lead with traction, founder-market fit, and the specific reason a tech-enabled approach changes the unit economics of the healthcare problem you are solving. Indian metrics matter; the network is not particularly responsive to US-style narrative pitches. Caveats: founders should expect a more transactional relationship than with a traditional VC, with less hands-on portfolio support and a wider but shallower network than a focused fund. Use IPV as the early-round capital partner that gets your company off the ground in India and creates inbound interest from Series A institutionals, not as the value-add partner who will sit in your weekly leadership reviews.